# ë°°ê²½ ìë£Œ: PL3 ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ ì¤‘ ë™ì  ê²Œë†ˆ ìƒí˜¸ì‘ìš©

**ë°œí‘œ**: PL3 - Plenary Lecture 3
**ì¼ì‹œ**: 2025ë…„ 10ì›” 27ì¼ (ì›”) 13:00-13:40
**ì¥ì†Œ**: Convention Hall 1
**ì¢Œì¥**: Moon Jung Song (Korea University)
**ì¤‘ìš”ë„**: â­â­â­â­â­ (94/100ì ) - **Plenary Lecture! ë°”ì´ëŸ¬ìŠ¤/ë¶„ììƒë¬¼í•™ ì—°êµ¬ì í•„ìˆ˜**

---

## ğŸ¯ ë°œí‘œ ê°œìš”

**ì—°ì‚¬**: Matthew D. Weitzman
**ì†Œì†**: University of Pennsylvania & Children's Hospital of Philadelphia, USA
**ì§ì±…**: Professor of Pathology and Laboratory Medicine
**ì œëª©**: Dynamic genome interactions during virus infection

### ì™œ ì´ ë°œí‘œê°€ ì¤‘ìš”í•œê°€?

- ğŸ† **Plenary Lecture**: MSK2025ì˜ ìµœê³  ìˆ˜ì¤€ ë°œí‘œ
- ğŸ§¬ **DNA ì†ìƒ ë°˜ì‘ê³¼ ë°”ì´ëŸ¬ìŠ¤**: Host DNA damage responseê°€ ë°”ì´ëŸ¬ìŠ¤ ê²Œë†ˆì„ ì¸ì‹í•˜ëŠ” ë©”ì»¤ë‹ˆì¦˜
- ğŸ”¬ **2024 ìµœì‹  ì—°êµ¬**: Viral biomolecular condensates, APOBEC3A, SMC5/6 complex
- ğŸ… **2024 AAM Fellow** ì„ ì¶œ (American Academy of Microbiology)
- ğŸ’¡ **Host-virus arms race**: ì„ ì²œë©´ì—­ê³¼ ë°”ì´ëŸ¬ìŠ¤ íšŒí”¼ ì „ëµ

### ë© êµ¬ì„±ì›ë“¤ì—ê²Œ ìœ ìš©í•œ ì´ìœ 

**ë°”ì´ëŸ¬ìŠ¤í•™ ì—°êµ¬ì**:
- Adenovirus, Herpesvirusì˜ ê²Œë†ˆ-ìˆ™ì£¼ ìƒí˜¸ì‘ìš©
- Viral replication compartment í˜•ì„± ë©”ì»¤ë‹ˆì¦˜
- Biomolecular condensates in viral assembly

**ë¶„ììƒë¬¼í•™/ì„¸í¬ìƒë¬¼í•™ ì—°êµ¬ì**:
- DNA damage response (DDR) pathway
- MRN complex, ATM, SMC5/6ì˜ ì—­í• 
- Chromatin dynamics during infection

**ë©´ì—­í•™ ì—°êµ¬ì**:
- Innate immunity: DNA sensing
- APOBEC3A-mediated antiviral defense
- Virusì˜ ë©´ì—­ íšŒí”¼ ì „ëµ

**ì•” ì—°êµ¬ì**:
- DDR pathwayì˜ ì´ì¤‘ì  ì—­í•  (í•­ë°”ì´ëŸ¬ìŠ¤ vs. ë°œì•”)
- Oncolytic virus therapy ë©”ì»¤ë‹ˆì¦˜

---

## ğŸ“‹ ì—°ì‚¬ ë°°ê²½ ë° ìµœê·¼ ì—°êµ¬

### Matthew D. Weitzman êµìˆ˜ ì†Œê°œ

**í˜„ì¬ ì§ìœ„**:
- **Professor**, Department of Pathology and Laboratory Medicine, UPenn
- **Investigator**, Children's Hospital of Philadelphia (CHOP) Research Institute
- **Director**, Bio-Imaging Core Facility

**ì£¼ìš” ì—°êµ¬ ë¶„ì•¼**:
- DNA virus-host interactions
- DNA damage response as innate immunity
- Viral genome replication and assembly
- Chromatin modulation by viruses

**ì£¼ìš” ë°œê²¬**:
```
1. MRN complex = Mammalian DNA virus sensor
   â†’ í•µ ë‚´ ë°”ì´ëŸ¬ìŠ¤ ê²Œë†ˆ ì¸ì‹ì˜ í•µì‹¬

2. DDR machinery = Intrinsic barrier to virus infection
   â†’ Host defenseì˜ ìƒˆë¡œìš´ ì¸µ

3. Viral biomolecular condensates
   â†’ Adenovirus L1-52/55K proteinì˜ phase separation
```

**ìµœê·¼ ìˆ˜ìƒ**:
- **2024**: Fellow of the American Academy of Microbiology (AAM)

### ìµœê·¼ ì£¼ìš” ì—°êµ¬ ì„±ê³¼ (2024)

#### 1. The EMBO Journal (January 2024) - Viral Condensates

**ë…¼ë¬¸ ì œëª©**: "Phosphorylation regulates viral biomolecular condensates to promote infectious progeny production"

**ì €ì**: Nicholas Grams, Matthew Charman, et al.

**í•µì‹¬ ë°œê²¬**:
```
Adenovirus L1-52/55K protein (52K)
         â†“
Biomolecular condensate í˜•ì„± (LLPS!)
         â†“
Viral genome packaging ë° capsid assembly ì¡°ì ˆ
         â†“
Phosphorylation (Ser28, Ser75)
         â†“
Liquid-like properties ì´‰ì§„
         â†“
Infectious progeny ìƒì‚° ì¦ê°€
```

**ì˜ë¯¸**:
- ë°”ì´ëŸ¬ìŠ¤ë„ **phase separation** ì´ìš©!
- Condensate = Viral assembly factory
- Phosphorylation switchë¡œ ì¡°ì ˆ

#### 2. Viruses (May 2024) - Protein-DNA Interactions Review

**ë…¼ë¬¸ ì œëª©**: "Identifying Protein Interactions with Viral DNA Genomes during Virus Infection"

**ì €ì**: Jessica E. Packard, Namrata Kumar, Matthew D. Weitzman, Jill A. Dembowski

**ë‚´ìš©**:
- Herpesviruses, Adenoviruses, Vaccinia virusì˜ host protein-viral genome interactions
- Proteomic approaches (iPOND, ChIP-MS, BioID)
- DDR pathwayì˜ ì—­í• 

#### 3. The EMBO Journal (June 2024) - SMC5/6 Complex

**ë…¼ë¬¸ ì œëª©**: "The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress"

**í•µì‹¬**:
- **APOBEC3A**: Cytidine deaminase, í•­ë°”ì´ëŸ¬ìŠ¤ ë‹¨ë°±ì§ˆ
- ssDNAì— Câ†’U deamination â†’ Mutation, DNA damage
- **SMC5/6 complex**: DNA repair, replication stress í•´ì†Œ
- SMC5/6ê°€ ì—†ìœ¼ë©´ APOBEC3Aê°€ genome instability ìœ ë°œ

**ë°”ì´ëŸ¬ìŠ¤ì™€ì˜ ì—°ê´€**:
- APOBEC3AëŠ” HIV, HPV, HBV ë“±ì„ ê³µê²©
- ë°”ì´ëŸ¬ìŠ¤ëŠ” APOBEC3Aë¥¼ íšŒí”¼í•˜ë ¤ ì§„í™”
- HostëŠ” SMC5/6ë¡œ self-damage ë°©ì§€

---

## ğŸ”¬ ë°œí‘œ ì˜ˆìƒ ë‚´ìš©

### Part 1: DNA Damage Response (DDR)ì™€ ë°”ì´ëŸ¬ìŠ¤ ì¸ì‹

#### 1-1. DDR Pathway ê°œìš”

**ì „í†µì  ì´í•´**: DNA ì†ìƒ ìˆ˜ë¦¬ ì‹œìŠ¤í…œ

**Weitzmanì˜ ë°œê²¬**: **Intrinsic antiviral defense!**

**ì£¼ìš” DDR ë‹¨ë°±ì§ˆ**:
```yaml
Sensors (ê°ì§€):
  - MRN complex (Mre11-Rad50-Nbs1)
  - Ku70/80
  - DNA-PK

Transducers (ì‹ í˜¸ì „ë‹¬):
  - ATM (Ataxia Telangiectasia Mutated)
  - ATR (ATM and Rad3-related)
  - Chk1, Chk2

Effectors (ì‹¤í–‰):
  - p53
  - H2AX (Î³H2AX í˜•ì„±)
  - DNA repair enzymes
```

#### 1-2. MRN Complex: ë°”ì´ëŸ¬ìŠ¤ ê²Œë†ˆì˜ ê°ì‹œì

**êµ¬ì¡°**:
- **Mre11**: Nuclease activity (3'â†’5' exonuclease)
- **Rad50**: ATPase, DNA tethering
- **Nbs1** (Nibrin): Signaling adaptor, ATM recruitment

**ì •ìƒ ê¸°ëŠ¥**: DNA double-strand break (DSB) ì¸ì‹

**Weitzman ë°œê²¬ (2010s)**:
```
Adenovirus ê°ì—¼
    â†“
MRN complexê°€ viral genome ì¸ì‹ (Linear dsDNA!)
    â†“
ATM í™œì„±í™”
    â†“
    â”œâ†’ DDR signaling (í•­ë°”ì´ëŸ¬ìŠ¤)
    â””â†’ Viral genome degradation ì‹œë„
```

**ë°”ì´ëŸ¬ìŠ¤ì˜ ë°˜ê²©**:
```
Adenovirus E4-ORF3:
  â†’ MRN complexë¥¼ PML bodiesë¡œ ê²©ë¦¬ (Sequestration!)
  â†’ Viral genomeì— ì ‘ê·¼ ëª» í•˜ê²Œ í•¨

Adenovirus E1B-55K + E4-ORF6:
  â†’ E3 ubiquitin ligase í˜•ì„±
  â†’ Mre11, p53 ë“±ì„ degradation

HSV-1 ICP0:
  â†’ E3 ubiquitin ligase
  â†’ DDR ë‹¨ë°±ì§ˆ ì œê±°
```

**Host-virus arms race**!

#### 1-3. ATM/ATR Signaling

**ATM í™œì„±í™”**:
```
MRN complex (DSB ì¸ì‹)
    â†“
ATM auto-phosphorylation (Ser1981)
    â†“
ATM kinase activity â†‘
    â†“
Downstream targets phosphorylation:
  - Chk2, p53, H2AX, SMC1...
```

**ATR í™œì„±í™”**:
```
RPA-coated ssDNA (Replication stress)
    â†“
ATR-ATRIP complex recruitment
    â†“
Chk1 phosphorylation
    â†“
Cell cycle arrest, Replication fork stabilization
```

**ë°”ì´ëŸ¬ìŠ¤ì˜ ì´ìš©**:
- ì¼ë¶€ ë°”ì´ëŸ¬ìŠ¤ëŠ” DDRì„ **hijack**í•˜ì—¬ replicationì— ì´ìš©!
- ì˜ˆ: AdenovirusëŠ” ATMì„ viral replication centerë¡œ ë™ì›

### Part 2: Viral Replication Compartments (VRCs)

#### 2-1. VRCë€?

**ì •ì˜**:
- ë°”ì´ëŸ¬ìŠ¤ê°€ ìˆ™ì£¼ í•µ ë˜ëŠ” ì„¸í¬ì§ˆì— ë§Œë“œëŠ” **replication factory**
- Viral DNA ë³µì œ, transcription, capsid assemblyê°€ ì¼ì–´ë‚˜ëŠ” ì¥ì†Œ

**íŠ¹ì§•**:
```yaml
í˜•íƒœ:
  - Membraneless organelle
  - Biomolecular condensate (LLPS!)
  - Distinct from host chromatin

ìœ„ì¹˜:
  - í•µ: Adenovirus, Herpesvirus
  - ì„¸í¬ì§ˆ: Poxvirus, Mimivirus

êµ¬ì„±:
  - Viral DNA genomes
  - Viral replication proteins
  - Host factors (recruited)
```

#### 2-2. Adenovirus Replication Centers

**í˜•ì„± ê³¼ì •**:
```
E1A expression (immediate early)
    â†“
Cell cycle entry ìœ ë„
    â†“
E2 proteins (DNA polymerase, DBP, pTP)
    â†“
Viral DNA replication ì‹œì‘
    â†“
Replication centers í˜•ì„± (5-10ê°œ/í•µ)
    â†“
Late proteins (L1-52/55K) ìœ ì…
    â†“
Genome packaging & capsid assembly
```

**Biomolecular condensateë¡œì„œì˜ VRC**:

**ì¦ê±°** (2024 EMBO J ë…¼ë¬¸):
- **L1-52/55K protein**ì´ LLPS í˜•ì„±
- **Intrinsically disordered regions (IDRs)** ë³´ìœ 
- Liquid-like properties: FRAP ì‹¤í—˜ìœ¼ë¡œ í™•ì¸
- Phosphorylationìœ¼ë¡œ condensate ì„±ì§ˆ ì¡°ì ˆ

**ê¸°ëŠ¥ì  ì˜ë¯¸**:
```
Condensate ë‚´ë¶€:
  â†’ High concentration of viral DNA + proteins
  â†’ Genome packaging íš¨ìœ¨ ì¦ê°€
  â†’ Capsid assembly ê³µê°„ì  ì œì•½
  â†’ Host defense factors ë°°ì œ
```

#### 2-3. Herpesvirus VRCs

**HSV-1 replication compartments**:

**ì´ˆê¸°**: **Pre-replicative sites (Pre-RS)**
- ND10/PML bodies ê·¼ì²˜ í˜•ì„±
- Viral IE proteins (ICP4, ICP0) ì¶•ì 

**ì¤‘ê¸°**: **Replication compartments (RCs)**
- Viral DNA ë³µì œ
- ICP8 (SSB), UL42 (processivity factor) ë†ì¶•

**í›„ê¸°**: **Capsid assembly ì‹œì‘**
- Portal protein, scaffolding protein ìœ ì…

**Host factors ë™ì›**:
```
Positive factors (ë°”ì´ëŸ¬ìŠ¤ê°€ í•„ìš”):
  - RPA (ssDNA binding)
  - Topoisomerases
  - DNA-PK (ì¼ë¶€ ê¸°ëŠ¥)

Negative factors (ë°”ì´ëŸ¬ìŠ¤ê°€ ë°°ì œ):
  - PML
  - MRN complex
  - APOBEC3 family
```

### Part 3: APOBEC3A - Cytidine Deaminaseì˜ ì´ì¤‘ì„±

#### 3-1. APOBEC3A ì†Œê°œ

**APOBEC3 family**:
- **A3A, A3B, A3C, A3D, A3F, A3G, A3H** (ì¸ê°„ì— 7ê°œ)
- Cytidine deaminase: **C â†’ U** (DNA ë˜ëŠ” RNAì—ì„œ)

**A3A íŠ¹ì§•**:
- **ssDNA**ì— ì‘ìš©
- ê°•ë ¥í•œ í•­ë°”ì´ëŸ¬ìŠ¤ í™œì„± (HIV, HPV, HBV, AAV)
- ë°œí˜„: Keratinocytes, myeloid cells (IFN ìœ ë„ ì‹œ)

#### 3-2. í•­ë°”ì´ëŸ¬ìŠ¤ ë©”ì»¤ë‹ˆì¦˜

**ì‘ë™ ì›ë¦¬**:
```
Virus infection
    â†“
IFN response â†’ A3A ë°œí˜„ ì¦ê°€
    â†“
Viral genome replication ì¤‘ ssDNA ë…¸ì¶œ
    â†“
A3A binding to ssDNA
    â†“
C â†’ U deamination
    â†“
    â”œâ†’ Mutation (Hypermutation)
    â”œâ†’ DNA damage (Uracil glycosylase â†’ AP site)
    â””â†’ Genome instability â†’ Viral inactivation
```

**íš¨ê³¼**:
- **HIV**: G-to-A hypermutation â†’ Viral protein ê¸°ëŠ¥ ìƒì‹¤
- **HPV**: Episomal DNA ì†ìƒ
- **AAV**: Single-strand DNA genome ì§ì ‘ íƒ€ê²©

#### 3-3. Host Genomeì— ëŒ€í•œ ìœ„í—˜ì„±

**ë¬¸ì œ**:
- A3Aê°€ host DNAì—ë„ ì‘ìš© ê°€ëŠ¥!
- LINE-1 retrotransposon replication ì¤‘ ssDNA ë…¸ì¶œ â†’ A3A ê³µê²©

**ê²°ê³¼** (Weitzman íŒ€ ì—°êµ¬):
```
A3A overexpression
    â†“
Replication stress
    â†“
ssDNA ì¦ê°€
    â†“
C â†’ U deamination (host genome!)
    â†“
Genomic instability
    â†“
Cell cycle arrest, Apoptosis
```

**ì•”ê³¼ì˜ ì—°ê´€**:
- A3A/A3B overexpression â†’ Mutation signature in cancers
- "APOBEC signature" in breast, bladder, lung cancer
- ì–‘ë‚ ì˜ ê²€: í•­ë°”ì´ëŸ¬ìŠ¤ vs. ë°œì•”

#### 3-4. SMC5/6 Complexì˜ ë³´í˜¸ ì—­í• 

**SMC5/6 complex**:
- Structural Maintenance of Chromosomes 5/6
- DNA repair, replication fork stability

**Weitzman 2024 EMBO J ë°œê²¬**:
```
APOBEC3A activity
    â†“
Replication stress
    â†“
SMC5/6 recruitment
    â†“
    â”œâ†’ Replication fork protection
    â”œâ†’ DNA repair coordination
    â””â†’ Genomic stability ìœ ì§€
```

**SMC5/6 loss**:
```
A3A + SMC5/6 ê²°í•
    â†“
Massive DNA damage
    â†“
Chromosomal aberrations
    â†“
Cell death
```

**ì¹˜ë£Œì  í•¨ì˜**:
- SMC5/6 inhibitor + A3A activation â†’ Cancer cell killing?
- í•˜ì§€ë§Œ ì •ìƒ ì„¸í¬ë„ ì†ìƒ ìœ„í—˜

### Part 4: Viral Evasion Strategies

#### 4-1. DDR íšŒí”¼

**Strategy 1: DDR ë‹¨ë°±ì§ˆ degradation**
```
Adenovirus E1B-55K/E4-ORF6:
  â†’ Cullin-based E3 ligase
  â†’ Mre11, p53, DNA ligase IV ubiquitination
  â†’ Proteasomal degradation

HSV-1 ICP0:
  â†’ RING finger E3 ligase
  â†’ PML, Sp100, DNA-PK degradation
```

**Strategy 2: Sequestration (ê²©ë¦¬)**
```
Adenovirus E4-ORF3:
  â†’ MRN complexë¥¼ nuclear tracksë¡œ ê²©ë¦¬
  â†’ Viral genomeì— ì ‘ê·¼ ëª» í•¨

HPV E2:
  â†’ ATM/ATR signaling ì–µì œ
```

**Strategy 3: DDR hijacking**
```
ì¼ë¶€ ë°”ì´ëŸ¬ìŠ¤:
  â†’ DDR ë‹¨ë°±ì§ˆì„ replicationì— ì´ìš©
  â†’ ATMì„ viral replication centersë¡œ ë™ì›
  â†’ DNA-PKë¥¼ genome packagingì— í™œìš©
```

#### 4-2. APOBEC3 íšŒí”¼

**HIV Vif protein**:
```
HIV Vif
    â†“
A3G (and A3F) binding
    â†“
Cullin5-based E3 ligase í˜•ì„±
    â†“
A3G ubiquitination & degradation
    â†“
HIV genome hypermutation ë°©ì§€
```

**HPV E6/E7**:
- A3A ë°œí˜„ ì–µì œ
- Interferon signaling ì°¨ë‹¨

**AAV (Adeno-Associated Virus)**:
- A3Aì— ë¯¼ê° â†’ Helper virus (Adenovirus) í•„ìš”
- Adenovirusê°€ A3Aë¥¼ ì–µì œí•´ì¤Œ

---

## ğŸ“ ë°°ê²½ ì§€ì‹

### DNA Damage Response (DDR) í•µì‹¬ ê°œë…

**DSB (Double-Strand Break) Repair Pathways**:

```yaml
1. NHEJ (Non-Homologous End Joining):
   - Ku70/80 â†’ DNA-PK â†’ Ligation
   - Fast, error-prone
   - G1/G0 phase

2. HR (Homologous Recombination):
   - MRN â†’ ATM â†’ BRCA1/2 â†’ RAD51
   - Accurate, uses sister chromatid
   - S/G2 phase
```

**Checkpoint activation**:
```
ATM/ATR
    â†“
Chk2/Chk1 phosphorylation
    â†“
Cdc25 inhibition
    â†“
Cell cycle arrest (G1/S or G2/M)
    â†“
ì‹œê°„ í™•ë³´ â†’ Repair or Apoptosis
```

### Liquid-Liquid Phase Separation (LLPS)

**ê°œë…**:
- ê· ì¼í•œ ìš©ì•¡ì´ ë‘ ê°œì˜ ì•¡ì²´ ìƒìœ¼ë¡œ ë¶„ë¦¬
- Oil-water separationì²˜ëŸ¼
- ì„¸í¬ ë‚´: Membraneless organelles í˜•ì„±

**ì˜ˆì‹œ**:
```
- Nucleolus (rRNA + ribosomal proteins)
- P-bodies (mRNA degradation)
- Stress granules (translation stalled mRNA)
- DNA repair foci
- Viral replication compartments (NEW!)
```

**ë¶„ìì  íŠ¹ì§•**:
- **IDRs** (Intrinsically Disordered Regions) í•„ìˆ˜
- **Multivalent interactions** (weak, multiple)
- **Post-translational modifications**ë¡œ ì¡°ì ˆ (phosphorylation ë“±)

**FRAP (Fluorescence Recovery After Photobleaching)**:
- Liquid-like: ë¹ ë¥¸ recovery
- Gel-like: ëŠë¦° recovery
- Solid-like: No recovery

### APOBEC Family

**ì§„í™”ì  ê¸°ì›**:
- AID (Activation-Induced Deaminase): B cell antibody diversification
- APOBEC1: RNA editing (apoB mRNA)
- APOBEC3: Innate immunity (retrovirus/retrotransposon restriction)

**ê¸°ì§ˆ íŠ¹ì´ì„±**:
```
A3A: TC context (5'-TC-3')
A3G: CC context (5'-CC-3')
A3B: TC context (A3Aì™€ ìœ ì‚¬)
```

**í™œì„± ì¡°ì ˆ**:
```
Positive:
  - IFN signaling
  - Viral infection
  - Keratinocyte differentiation

Negative:
  - Viral proteins (Vif, E6/E7)
  - CCT chaperonin (A3A binding)
```

---

## ğŸ’¡ ì˜ˆìƒ ì§ˆë¬¸ ë° í† ë¡  í¬ì¸íŠ¸

### ë°œí‘œ ì¤‘/í›„ ë¬¼ì–´ë³¼ ì§ˆë¬¸ë“¤

**1. VRC condensateì˜ ë¬¼ë¦¬ì  ì„±ì§ˆ**:
> "Adenovirus VRC condensateì˜ viscosityë‚˜ surface tensionì„ ì¸¡ì •í•˜ì…¨ë‚˜ìš”? ì‹œê°„ì— ë”°ë¼ ë³€í•˜ë‚˜ìš”?"

**ë°°ê²½**: LLPSì˜ ë¬¼ë¦¬í™”í•™ì  íŠ¹ì„± ì´í•´

**2. DDRì˜ ì´ì¤‘ì  ì—­í• **:
> "ë°”ì´ëŸ¬ìŠ¤ë§ˆë‹¤ DDRì„ ë°©í•´í•˜ê±°ë‚˜ í™œìš©í•˜ëŠ” ì „ëµì´ ë‹¤ë¥¸ë°, ì–´ë–¤ ìš”ì¸ì´ ê²°ì •í•˜ë‚˜ìš”?"

**ë°°ê²½**: Host-virus co-evolution

**3. A3Aì™€ ì•”**:
> "A3Aì˜ í•­ë°”ì´ëŸ¬ìŠ¤ í™œì„±ì„ ìœ ì§€í•˜ë©´ì„œ ë°œì•” ìœ„í—˜ì„ ì¤„ì¼ ìˆ˜ ìˆëŠ” ë°©ë²•ì´ ìˆì„ê¹Œìš”?"

**ë°°ê²½**: ì¹˜ë£Œì  ì‘ìš©

**4. Oncolytic virus therapy**:
> "DDR deficient cancer cellsë¥¼ íƒ€ê²Ÿí•˜ëŠ” oncolytic virus ê°œë°œì´ ê°€ëŠ¥í•œê°€ìš”?"

**ë°°ê²½**: DDR ì§€ì‹ì˜ ì•” ì¹˜ë£Œ ì‘ìš©

**5. ë‹¤ë¥¸ ë°”ì´ëŸ¬ìŠ¤ family**:
> "RNA virusë„ host DDRê³¼ ìƒí˜¸ì‘ìš©í•˜ë‚˜ìš”? DNA virusì— êµ­í•œëœ í˜„ìƒì¸ê°€ìš”?"

**ë°°ê²½**: ì¼ë°˜í™” ê°€ëŠ¥ì„±

---

## ğŸ“š ì¶”ì²œ ì‚¬ì „ í•™ìŠµ ìë£Œ

### í•„ìˆ˜ ë…¼ë¬¸

**1. Weitzman íŒ€ 2024 ì—°êµ¬**:
```
1) EMBO J, 2024 (Jan)
   "Phosphorylation regulates viral biomolecular condensates..."
   â†’ Viral LLPS ë©”ì»¤ë‹ˆì¦˜

2) Viruses, 2024 (May)
   "Identifying Protein Interactions with Viral DNA Genomes..."
   â†’ Proteomic ë°©ë²•ë¡  ë¦¬ë·°

3) EMBO J, 2024 (Jun)
   "The SMC5/6 complex prevents genotoxicity upon APOBEC3A..."
   â†’ A3Aì™€ genome stability
```

**2. DDR-virus interaction ë¦¬ë·°**:
```
4) Annual Review of Virology, 2018
   "Virus DNA Replication and the Host DNA Damage Response"
   â†’ ì „ì²´ ê°œë¡  (Weitzman ì €ì)
```

### í•µì‹¬ ê°œë… ë³µìŠµ

**ë°˜ë“œì‹œ ì•Œì•„ì•¼ í•  ìš©ì–´**:
- **DDR** (DNA Damage Response): DNA ì†ìƒ ê°ì§€ ë° ìˆ˜ë¦¬ ì‹œìŠ¤í…œ
- **MRN complex**: Mre11-Rad50-Nbs1, DSB sensor
- **VRC** (Viral Replication Compartment): ë°”ì´ëŸ¬ìŠ¤ ë³µì œ ê³µì¥
- **LLPS** (Liquid-Liquid Phase Separation): ìƒ ë¶„ë¦¬
- **APOBEC3A**: Cytidine deaminase, í•­ë°”ì´ëŸ¬ìŠ¤ íš¨ì†Œ
- **SMC5/6**: DNA repair complex

---

## ğŸŒŸ ì´ ë°œí‘œì˜ í•˜ì´ë¼ì´íŠ¸

### Take-home Messages

**1. DDR = Intrinsic Antiviral Defense**:
- DNA repair ê¸°êµ¬ê°€ ì„ ì²œë©´ì—­ì˜ ì¼ë¶€!
- MRN complex = Viral genome sensor

**2. Viral Biomolecular Condensates**:
- ë°”ì´ëŸ¬ìŠ¤ë„ phase separation ì´ìš©
- Replication, assemblyì˜ íš¨ìœ¨ì  ì¡°ì§í™”

**3. APOBEC3Aì˜ ì–‘ë©´ì„±**:
- ê°•ë ¥í•œ í•­ë°”ì´ëŸ¬ìŠ¤ + ë°œì•” ìœ„í—˜
- SMC5/6ë¡œ self-damage ì¡°ì ˆ

**4. Host-Virus Arms Race**:
- DDR vs. Viral evasion
- ëŠì„ì—†ëŠ” ì§„í™”ì  ê²½ìŸ

### ë„¤íŠ¸ì›Œí‚¹ í¬ì¸íŠ¸

**Weitzman êµìˆ˜ì™€ ëŒ€í™” ì‹œ ì–¸ê¸‰í•˜ë©´ ì¢‹ì„ ì£¼ì œ**:
- "2024 AAM Fellow ì„ ì¶œ ì¶•í•˜ë“œë¦½ë‹ˆë‹¤!"
- "Viral condensateì˜ LLPS ì—°êµ¬ê°€ ì¸ìƒ ê¹Šì—ˆìŠµë‹ˆë‹¤"
- "MRN complex ë°œê²¬ì´ ë¶„ì•¼ë¥¼ ë°”ê¿¨ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤"
- "Oncolytic virus therapyì— DDR ì§€ì‹ì„ ì–´ë–»ê²Œ ì ìš©í•  ìˆ˜ ìˆì„ê¹Œìš”?"

**ê´€ë ¨ ì„¸ì…˜ ì—°ê³„**:
- **S1 (Bacterial Pathogenesis)**: Tao Dong (Phase separation in T6SS)
- **S7, S16, S17 (Virus sessions)**: ë°”ì´ëŸ¬ìŠ¤í•™ ì „ë°˜

---

## ğŸ“Š ë°œí‘œ í‰ê°€ ê¸°ì¤€

### ìš°ì„ ìˆœìœ„: â­â­â­â­â­ (94/100)

**ì°¸ì„ ì´ìœ **:
```
âœ… Plenary Lecture (ìµœê³  ë“±ê¸‰)
âœ… ì„¸ê³„ì  ì „ë¬¸ê°€ (2024 AAM Fellow)
âœ… ìµœì‹  ì—°êµ¬ (2024 EMBO J x2, Viruses)
âœ… ì¤‘ìš”í•œ ê°œë… (DDR as immunity)
âœ… í•™ì œê°„ ìœµí•© (ë©´ì—­, ì•”, ë°”ì´ëŸ¬ìŠ¤)
```

**ëˆ„ê°€ ë“¤ì–´ì•¼ í•˜ë‚˜**:
- âœ… **ë°”ì´ëŸ¬ìŠ¤í•™** ì—°êµ¬ì (í•„ìˆ˜!)
- âœ… **ë¶„ììƒë¬¼í•™** ì—°êµ¬ì
- âœ… **ë©´ì—­í•™** ì—°êµ¬ì (DDR as innate immunity)
- âœ… **ì•” ìƒë¬¼í•™** ì—°êµ¬ì (A3A, DDR)
- âœ… **ì„¸í¬ ìƒë¬¼í•™** ì—°êµ¬ì (LLPS, condensates)

**ë‚œì´ë„**:
- ì¤‘ê¸‰~ê³ ê¸‰ (DDR pathway ê¸°ë³¸ ì§€ì‹ ìˆìœ¼ë©´ ì¢‹ìŒ)
- í•˜ì§€ë§Œ ì¼ë°˜ ì²­ì¤‘ë„ ì¶©ë¶„íˆ ì´í•´ ê°€ëŠ¥í•œ ì„¤ëª… ì˜ˆìƒ

---

**ì‘ì„±ì¼**: 2025-10-26
**ì‘ì„±ì**: Conference Advisor (MSK2025 ì¤€ë¹„íŒ€)
**ì°¸ê³  ë¬¸í—Œ**: EMBO J 2024 (x2), Viruses 2024, Annual Rev. Virology 2018
